Background: Whether diminished pulsatility influences outcomes in patients with continuous-flow left ventricular assist devices (CF-LVAD) is largely undetermined. We sought to characterise the relationship between measured flow pulsatility and outcomes in patients with a HeartWare CF-LVAD (HVAD).
Methods: Log-files from 61 HVAD patients with pulsatility data were analysed. Mean, peak, trough flow and pulsatility (peak -trough flow) were extracted. A flow pulsatility index (PI) (pulsatility/mean flow) was calculated for each patient at 1, 3, 6, 9 and 12 months from HVAD patient log files. Patients were divided into tertiles reflecting low, intermediate and high pulsatility based on their average PI. Baseline demographics and outcomes were compared between groups. Outcomes compared were gastrointestinal bleeding (GIB), neurological events (NE) and pump thrombus (PT).
Results: Patients were divided into tertiles reflecting low (n = 21), intermediate (n = 19) and high (n = 21) pulsatility. There were no significant differences in demographics between groups according to pulsatility. Surprisingly, PT rates were significantly higher (p = 0.013) in the high pulsatility (n = 6, 29%) group compared to the low (n = 0, 0%) and intermediate (n = 1, 5%) groups. Binary logistic regression yielded low trough flow as an independent predictor of PT (OR 0.205, p = 0.028). NE (p = 0.113) and GIB (p = 0.607) did not differ significantly between groups.
Conclusion: Flow PI was positively associated with PT, likely due to an effect of low trough flow. This presents an important potential target for future therapeutic intervention. The widely accepted definition of pulmonary hypertension (PH) -a mean pulmonary artery pressure (mPAP) of >25 mmHg, has come under renewed focus at the 2018 6 th world PH symposium with healthy human studies showing that, on average, the mPAP was 14 ± 3.3 mmHg at rest. The mPAP is also affected by pulmonary artery wedge pressure (PAWP) and cardiac output (CO).
Aims: To provide a descriptive analysis of all patients with a mPAP of 21-25 mmHg referred to a specialist quaternary PH centre.
Methods: All patients referred for right heart catheter (RHC) at our institution between 2008 and 2018, with: an MPAP of 21-25 mmHg; pulmonary vascular resistance ≥3 Wood units, and; PAWP ≤15 mmHg were included. Data were extracted from the medical records for: aetiology; six-minute walk test (6MWT), and mortality.
Results: 59 patients were included, representing 3.5% of all cases with an mPAP >20 mmHg. The average age was 66.3 ± 13.8 years. Average 6MWT was 339.5 ± 110.9 m. There were a total of 13 deaths over the study period. Patients were classified according to aetiology of PH: 13 (22%) of patients were classified as group 1; 12 (20%) group 2; 22 (37%) group 3; 8 (14%) group 4; 1 (1.7%) group 5; and 3 (5%) unclear pathology.
